JP2023536008A5 - - Google Patents
Info
- Publication number
- JP2023536008A5 JP2023536008A5 JP2023523681A JP2023523681A JP2023536008A5 JP 2023536008 A5 JP2023536008 A5 JP 2023536008A5 JP 2023523681 A JP2023523681 A JP 2023523681A JP 2023523681 A JP2023523681 A JP 2023523681A JP 2023536008 A5 JP2023536008 A5 JP 2023536008A5
- Authority
- JP
- Japan
- Prior art keywords
- promoter
- viral vector
- sequence identity
- pharmaceutical composition
- isolated cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2010009.5A GB202010009D0 (en) | 2020-06-30 | 2020-06-30 | Vector |
| GB2010009.5 | 2020-06-30 | ||
| PCT/GB2021/051668 WO2022003357A1 (en) | 2020-06-30 | 2021-06-30 | Vector |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536008A JP2023536008A (ja) | 2023-08-22 |
| JP2023536008A5 true JP2023536008A5 (cg-RX-API-DMAC10.html) | 2024-07-08 |
Family
ID=71949697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523681A Pending JP2023536008A (ja) | 2020-06-30 | 2021-06-30 | ベクター |
Country Status (12)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202003618D0 (en) | 2020-03-12 | 2020-04-29 | Univ Bristol | Gene Therapy |
| WO2021257480A2 (en) | 2020-06-14 | 2021-12-23 | Catalyst Biosciences, Inc. | Complement factor i-related compositions and methods |
| GB202217332D0 (en) * | 2022-11-18 | 2023-01-04 | Univ Bristol | Methods |
| EP4410988A1 (en) * | 2023-01-31 | 2024-08-07 | Universitätsklinikum Hamburg-Eppendorf | An aav2-vector variant for targeted transfer of genes |
| EP4669359A1 (en) * | 2023-02-21 | 2025-12-31 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | MAFB PROMOTER FOR GENE THERAPY FOR DIABETES |
| GB202304841D0 (en) * | 2023-03-31 | 2023-05-17 | Purespring Therapeutics Ltd | Promoter |
| CN121013858A (zh) * | 2023-04-27 | 2025-11-25 | 俄勒冈健康与科学大学 | 靶向肾脏的aav衣壳及其使用方法 |
| GB202414499D0 (en) * | 2024-10-02 | 2024-11-13 | Purespring Therapeutics Ltd | Methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT904392E (pt) | 1996-10-17 | 2001-06-29 | Oxford Biomedica Ltd | Vectores retrovirais |
| US20050169914A1 (en) * | 2003-08-01 | 2005-08-04 | Colgan Sean P. | Novel functions for decay accelerating factor (DAF) in inflammation |
| US7745389B2 (en) * | 2005-02-14 | 2010-06-29 | University Of Iowa Research Foundation | Methods for treatment of age-related macular degeneration |
| EP2730282A1 (en) * | 2007-11-08 | 2014-05-14 | The General Hospital Corporation | Methods and compositions for the treatment of proteinuric diseases |
| EP3795581A3 (en) * | 2011-08-24 | 2021-06-09 | The Board of Trustees of the Leland Stanford Junior University | New avv capsid proteins for nucleic acid transfer |
| GB201403684D0 (en) * | 2014-03-03 | 2014-04-16 | King S College London | Vector |
| EP3359663A4 (en) * | 2015-09-24 | 2019-08-14 | The Trustees of The University of Pennsylvania | COMPOSITION AND METHOD FOR THE TREATMENT OF A COMPLEMENT-MEDIATED DISEASE |
| US12653168B2 (en) * | 2018-09-13 | 2026-06-16 | Regeneron Pharmaceuticals, Inc. | Complement factor H gene knockout rat as a model of C3 glomerulopathy |
-
2020
- 2020-06-30 GB GBGB2010009.5A patent/GB202010009D0/en not_active Ceased
-
2021
- 2021-06-30 EP EP21748644.8A patent/EP4172345A1/en active Pending
- 2021-06-30 WO PCT/GB2021/051668 patent/WO2022003357A1/en not_active Ceased
- 2021-06-30 MX MX2022016101A patent/MX2022016101A/es unknown
- 2021-06-30 US US18/011,592 patent/US20230175016A1/en active Pending
- 2021-06-30 CN CN202180046691.7A patent/CN115997025A/zh active Pending
- 2021-06-30 KR KR1020237003243A patent/KR20230056658A/ko active Pending
- 2021-06-30 IL IL299505A patent/IL299505A/en unknown
- 2021-06-30 AU AU2021300616A patent/AU2021300616A1/en active Pending
- 2021-06-30 JP JP2023523681A patent/JP2023536008A/ja active Pending
- 2021-06-30 BR BR112022026521A patent/BR112022026521A2/pt unknown
- 2021-06-30 CA CA3183830A patent/CA3183830A1/en active Pending